Obiettivo Develop transgenic mice with different mutation in the FMR1 gene.Study the biochemical abnormalities of these transgenic mice.Morphological, cellular and molecular studies of the brain in the mice.Studies of behaviour and cognitive function in these transgenic animals. To study the mechanisms that lead to mental retardation and behavioral abnormalities in the fragile X syndrome, we take advantage by the participants' expertise in molecular biology, neurobiology and knowledge of animal behavior. Fragile X mental retardation is caused by the absence of the FMR1 protein or by in missense mutation in the FMR1 protein. For this purpose we will engineer mice that have abnormalities in the FMR1 gene that will mimic the effect at the protein level as is seen in patient suffering from fragile X mental retardation. Animals will be prepared that produce no protein or a mutated FMR1 protein. By reintroduction of the gene in these animals we will bring the gene to expression into a limited number of tissues and/or cell types. These animals will be used to study clinical and biochemical abnormalities. These mice will be studied morphologically, electrophysiologically and molecularly. As fragile X patients show deficits in a number of behavior and cognitive functions, these mice will be subjected to a number of behavior or cognitive tests to determine which functions are affected and to try to understand which parts of the brain are important for the development of mental retardation. The studies on the transgenic mice might contribute to our understanding of behavior, learning and memory. Campo scientifico natural sciencesbiological sciencesneurobiologycognitive neurosciencenatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsnatural sciencesbiological sciencesgeneticsmutationnatural sciencesbiological sciencesbiological behavioural sciencesethologynatural sciencesbiological sciencesmolecular biology Programma(i) FP4-BIOMED 2 - Specific research, technological development and demonstration programme in the field of biomedicine and health, 1994-1998 Argomento(i) 3.4 - Genetic and immunological basis of neuromental diseases Invito a presentare proposte Data not available Meccanismo di finanziamento CSC - Cost-sharing contracts Coordinatore Erasmus Universiteit Rotterdam Contributo UE Nessun dato Indirizzo 50,Dr. Molewaterplein 3000 DR Rotterdam Paesi Bassi Mostra sulla mappa Costo totale Nessun dato Partecipanti (3) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto Born-Bunge Foundation Belgio Contributo UE Nessun dato Indirizzo 1,Universiteitsplein 2610 Wilrijk Mostra sulla mappa Costo totale Nessun dato Institut National de la Santé et de la Recherche Médicale Francia Contributo UE Nessun dato Indirizzo 123,Boulevard de Port-Royal 75674 Paris Mostra sulla mappa Costo totale Nessun dato UNIVERSITAIRE INSTELLING ANTWERPEN - UNIVERSITEIT ANTWERPEN Belgio Contributo UE Nessun dato Indirizzo 1,Universiteitsplein 1 2610 WILRIJK (ANTWERPEN) Mostra sulla mappa Costo totale Nessun dato
